XML 20 R7.htm IDEA: XBRL DOCUMENT v3.25.0.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Additional paid-in capital
Additional paid-in capital
Cumulative Effect, Period of Adoption, Adjustment
Accumulated deficit
Accumulated deficit
Cumulative Effect, Period of Adoption, Adjustment
Accumulated other comprehensive income (loss)
Class A common stock
Class A common stock
Common Stock
Class B common stock
Class B common stock
Common Stock
Beginning balance (in shares) at Dec. 31, 2021                 277,708   45,904
Beginning balance at Dec. 31, 2021 $ 811,359 $ (284,437) $ 1,494,512 $ (318,756) $ (680,829) $ 34,319 $ (2,645)   $ 277   $ 44
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Accounting Standards Update [Extensible List] Accounting Standards Update 2020-06 Cumulative Effect, Period of Adoption [Member]                    
Issuance of common stock in connection with acquisition (in shares)                 522    
Issuance of common stock in connection with acquisition $ 65,505   65,504           $ 1    
Issuance of restricted stock in connection with acquisition (in shares)                 52    
Issuance of common stock upon exercise of stock options (in shares) 2,484               249   2,194
Issuance of common stock upon exercise of stock options $ 10,000   9,998               $ 2
Repurchases of unvested common stock (in shares)                 (1)    
Issuance of common stock related to early exercised stock options (in shares)                     41
Vesting of shares issued upon early exercise of stock options 2,862   2,861               $ 1
Issuance of common stock related to settlement of RSUs (in shares)                 1,723   1,125
Issuance of common stock related to settlement of RSUs     (3)           $ 2   $ 1
Tax withholding on RSU settlement (in shares)                     (32)
Tax withholding on RSU settlement (2,483)   (2,483)                
Conversion of Class B to Class A Common stock (in shares)                 5,707   (5,707)
Conversion of Class B to Class A Common stock                 $ 6   $ (6)
Common stock issued under employee stock purchase plan (in shares)                 302    
Common stock issued under employee stock purchase plan 15,291   15,291                
Settlement of common stock in connection with convertible senior notes (in shares)                 299    
Settlement of common stock in connection with convertible senior notes (201)   (201)                
Stock-based compensation 208,700   208,700                
Net loss (193,381)       (193,381)       $ (167,770)   $ (25,611)
Other comprehensive (loss) income (9,251)           (9,251)        
Ending balance (in shares) at Dec. 31, 2022                 286,561   43,525
Ending balance at Dec. 31, 2022 $ 623,964   1,475,423   (839,891)   (11,896)   $ 286   $ 42
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Issuance of common stock upon exercise of stock options (in shares) 2,989               448   2,541
Issuance of common stock upon exercise of stock options $ 14,851   14,848               $ 3
Repurchases of unvested common stock (in shares)                 (17)    
Vesting of shares issued upon early exercise of stock options 1,761   1,760               $ 1
Issuance of common stock related to settlement of RSUs (in shares)                 3,291   398
Issuance of common stock related to settlement of RSUs     (4)           $ 3   $ 1
Tax withholding on RSU settlement (in shares)                 (105)   (18)
Tax withholding on RSU settlement (7,953)   (7,953)                
Conversion of Class B to Class A Common stock (in shares)                 7,003   (7,003)
Conversion of Class B to Class A Common stock                 $ 7   $ (7)
Common stock issued under employee stock purchase plan (in shares)                 447    
Common stock issued under employee stock purchase plan 19,083   19,082           $ 1    
Settlement of common stock in connection with convertible senior notes (in shares)                 461    
Settlement of common stock in connection with convertible senior notes 46   46                
Stock-based compensation 281,364   281,364                
Net loss (183,949)       (183,949)       $ (161,296)   $ (22,653)
Other comprehensive (loss) income 13,880           13,880        
Ending balance (in shares) at Dec. 31, 2023               298,089 298,089 39,443 39,443
Ending balance at Dec. 31, 2023 $ 763,047   1,784,566   (1,023,840)   1,984   $ 297   $ 40
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Issuance of common stock upon exercise of stock options (in shares) 2,984               247   2,735
Issuance of common stock upon exercise of stock options $ 12,905   12,902               $ 3
Issuance of common stock related to early exercised stock options (in shares)                     2
Vesting of shares issued upon early exercise of stock options 109   109                
Issuance of common stock related to settlement of RSUs (in shares)                 4,208    
Issuance of common stock related to settlement of RSUs     (4)           $ 4    
Tax withholding on RSU settlement (in shares)                 (195)    
Tax withholding on RSU settlement (16,774)   (16,774)                
Conversion of Class B to Class A Common stock (in shares)                 5,217   (5,217)
Conversion of Class B to Class A Common stock                 $ 6   $ (6)
Common stock issued under employee stock purchase plan (in shares)                 326    
Common stock issued under employee stock purchase plan 19,796   19,796                
Other 1,689   1,689                
Stock-based compensation 350,466   350,466                
Net loss (78,800)       (78,800)       $ (69,975)   $ (8,825)
Other comprehensive (loss) income (6,237)           (6,237)        
Ending balance (in shares) at Dec. 31, 2024               307,892 307,892 36,963 36,963
Ending balance at Dec. 31, 2024 $ 1,046,201   $ 2,152,750   $ (1,102,640)   $ (4,253)   $ 307   $ 37